blog.aids.gov — HIV Policy & Programs. Research. New Media.
HIV Policy & Programs. Research. New Media.
FOR IMMEDIATE RELEASE Wednesday, June 5, 2013 MEDIA AVAILABILITY NIH Scientists Discover How HIV Kills Immune Cells Findings Have Implications for HIV Treatment WHAT: Untreated HIV infection destroys a person’s immune system by killing infection-fighting cells, but precisely when and how HIV wreaks this destruction has been a mystery until now. New research by scientists…
May 18th was HIV Vaccine Awareness Day, and we wanted to remind you of several posts we did last week on that subject. On Friday, we featured a guest post, Moving Forward on HIV Vaccine Awareness Day, by Dr. Nelson Michael, director of the U.S. Military HIV Research Program. And then we posted this video…
May 18th is HIV Vaccine Awareness Day (HVAD), led by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. We spoke to Dr. Carl Dieffenbach at NIH, who had this to say about HIV Vaccine Awareness Day: “[On Vaccine Awareness Day] we can take a moment to acknowledge the…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will stop administering injections in its HVTN 505 clinical trial of an investigational HIV vaccine regimen because an independent data and safety monitoring board (DSMB) found during a scheduled interim review that the vaccine regimen did not prevent HIV infection nor…
Read the statement about this study from NIH’s National Institute of Allergy and Infectious Diseases. Read the statement from Ambassador Eric Goosby, U.S. Global AIDS Coordinator. The story that captured global headlines from the 20th Conference on Retroviruses and Opportunistic Infections (CROI) this week was that of a toddler ‘functionally cured’ of HIV infection. We…
According to findings of a major HIV prevention trial presented Monday, March 4, 2013 at the 20th Conference on Retroviruses and Opportunistic Infections (CROI), study participants who received daily oral pre-exposure prophylaxis (PrEP) did not experience any protection against HIV compared to those in the placebo arm, likely because very few were taking the study…
Discovery Provides Clues for Potentially Eliminating HIV Infection in Other Children Editor’s note: NIH issued this news release this afternoon about findings announced at the 2013 Conference on Retroviruses and Opportunistic Infections (CROI) which began today in Atlanta, Georgia. The session at which the investigators will be reporting their findings in detail will be webcast…
Last week in Washington, DC, researchers, clinical and public health providers, advocates, federal leaders and representatives of health departments, professional societies, academia, and the pharmaceutical sector gathered for important discussions at the 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care . Secretary of Health and Human Services Kathleen Sebelius…
